Min Dong

Senior Principal Scientist
Johnson & Johnson Innovative Medicine

Poster(s):

• (M-088) PK/PD Analysis of the Primary Endpoint for Nipocalimab in Sjögren's Disease
  Monday, October 20, 2025

  7:00 AM - 5:00 PM MDT